Compositions for the treatment of inflammation of the gastrointestinal tract
AssigneeMeritage Pharma, Inc.
InventorMalcolm Hill
Life of this patent
Estimating the term…
Abstract
Provided herein are methods for treating the symptoms of and inflammation associated with gastroesophageal reflux disease (GERD) and other conditions. Also provided herein are pharmaceutical compositions useful for the methods of the present invention.
Claims45
1-42. (canceled)
A method of treating or alleviating the symptoms of, or inflammation due to, gastroesophageal reflux disease (GERD) in an individual comprising orally administering for topical delivery to the gastrointestinal tract a therapeutically effective amount of a corticosteroid to the individual, the corticosteroid orally administered to the esophagus of the individual in the form of a pharmaceutical composition having a viscosity of at least 2 cP.
A method of treating or alleviating the symptoms of, or inflammation due to, gastroesophageal reflux disease (GERD) in an individual comprising orally administering for topical delivery to the esophagus of the individual a therapeutically effective amount of a corticosteroid to the individual, the corticosteroid orally administered in the form of a pharmaceutical composition, wherein the corticosteroid is the sole pharmaceutically active ingredient of the composition.
Dependencies are inferred from the claim text.